arrow
M

Masahiro Kido

Kobe University
H指数:27
被引数:3,461

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of intrahepatic lesions on lesion-specific response rates in patients with hepatocellular carcinoma treated with lenvatinib or immune checkpoint inhibitors

肝内病灶对接受仑伐替尼或免疫检查点抑制剂治疗的肝细胞癌患者病灶特异性应答率的影响

HPB
IF2.4
2025-11-150
PRE
ASO Visual Abstract: Short- and Long-Term Outcomes after Pancreatectomy for Pancreatic Cancer in Patients with Prior Esophagectomy for Esophageal Cancer

ASO视觉摘要:胰腺癌患者行胰腺切除术的短期和长期预后,该患者曾因食管癌行食管切除术

2025-11-120
PRE
Utility of Oncological Resectability Criteria in Recurrent Hepatocellular Carcinoma After Hepatectomy

肝切除术后复发性肝细胞癌中肿瘤可切除标准的实用性

2025-11-010
OA
Multidisciplinary strategies including local treatment to achieve drug-free status after atezolizumab plus bevacizumab treatment in hepatocellular carcinoma

多学科策略包括局部治疗,旨在实现阿替利珠单抗联合贝伐珠单抗治疗后肝细胞癌患者的无药状态。

2025-10-010
OA
Exploring the potential utility of modified difficulty scores based on the IWATE criteria for assessing the surgical difficulty of laparoscopic repeat liver resection

基于IWATE标准探索修改后难度评分在评估腹腔镜重复肝切除术手术难度方面的潜在应用价值

2025-09-010
PRE
Association between tumor morphology and efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma

肿瘤形态与阿特珠单抗联合贝伐单抗治疗晚期肝癌疗效的关系

2024-02-144
PRE
ASO Visual Abstract: The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases
2023-07-120
PRE
The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases
2023-06-294
PRE